Title : First-line osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status.

Pub. Date : 2022 Jan

PMID : 34758637






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 First-line osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status. osimertinib epidermal growth factor receptor Homo sapiens